SLC2A10

solute carrier family 2 member 10, the group of Solute carrier family 2

Basic information

Region (hg38): 20:46709649-46736347

Links

ENSG00000197496NCBI:81031OMIM:606145HGNC:13444Uniprot:O95528AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • arterial tortuosity syndrome (Definitive), mode of inheritance: AR
  • arterial tortuosity syndrome (Strong), mode of inheritance: AR
  • arterial tortuosity syndrome (Supportive), mode of inheritance: AR
  • arterial tortuosity syndrome (Definitive), mode of inheritance: AR
  • arterial tortuosity syndrome (Strong), mode of inheritance: AR
  • familial thoracic aortic aneurysm and aortic dissection (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Arterial tortuosity syndromeARCardiovascularIndividuals appear to be at increased risk of cradiovascular manifestations, such as ischemic events, arterial aneurysm, and other findings, and preventive measures and prompt treatment may be beneficialCardiovascular; Dermatologic; Genitourinary; Musculoskeletal; Renal6033167; 12801113; 16550171; 17935213; 18565096; 19508422; 19781076; 29323665

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC2A10 gene.

  • Arterial tortuosity syndrome (10 variants)
  • Familial thoracic aortic aneurysm and aortic dissection (3 variants)
  • not provided (3 variants)
  • SLC2A10-related disorder (1 variants)
  • Cardiovascular phenotype (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC2A10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
140
clinvar
140
missense
1
clinvar
7
clinvar
230
clinvar
9
clinvar
4
clinvar
251
nonsense
3
clinvar
4
clinvar
7
start loss
0
frameshift
7
clinvar
5
clinvar
1
clinvar
13
inframe indel
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
4
clinvar
1
clinvar
5
splice region
4
4
8
non coding
43
clinvar
45
clinvar
29
clinvar
117
Total 12 20 276 194 33

Highest pathogenic variant AF is 0.000118

Variants in SLC2A10

This is a list of pathogenic ClinVar variants found in the SLC2A10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-46709677-G-T Arterial tortuosity syndrome Uncertain significance (Jan 13, 2018)338587
20-46709682-G-T Arterial tortuosity syndrome Uncertain significance (Jan 13, 2018)896229
20-46709706-G-GC not specified Likely benign (Apr 03, 2017)508341
20-46709710-C-T not specified • Arterial tortuosity syndrome Benign (Jan 12, 2018)139184
20-46709715-A-G Arterial tortuosity syndrome Conflicting classifications of pathogenicity (Jan 13, 2018)338588
20-46709722-C-T not specified • Arterial tortuosity syndrome • Familial thoracic aortic aneurysm and aortic dissection Conflicting classifications of pathogenicity (Apr 30, 2024)139185
20-46709727-C-G SLC2A10-related disorder Likely benign (Jun 29, 2022)3036380
20-46709737-A-G Arterial tortuosity syndrome Conflicting classifications of pathogenicity (Mar 26, 2024)2017181
20-46709737-A-T Familial thoracic aortic aneurysm and aortic dissection Likely pathogenic (Apr 17, 2024)3319431
20-46709740-G-A Arterial tortuosity syndrome Uncertain significance (May 27, 2022)2063252
20-46709746-T-A Familial thoracic aortic aneurysm and aortic dissection Uncertain significance (Jun 30, 2021)2442965
20-46709749-C-G not specified • Arterial tortuosity syndrome Likely benign (Jun 24, 2024)382501
20-46709750-G-A Arterial tortuosity syndrome Likely benign (Sep 09, 2023)1159163
20-46709754-G-C Arterial tortuosity syndrome Likely benign (Dec 23, 2022)2750114
20-46709754-G-T Arterial tortuosity syndrome Likely benign (Jan 29, 2022)2172806
20-46709968-C-T Likely benign (Aug 03, 2018)1223421
20-46724806-AGGAT-A Benign (Aug 06, 2019)1270430
20-46724806-A-AGGAT Benign (Nov 14, 2019)1283392
20-46724875-C-CGGACGGAT Likely benign (Sep 21, 2019)1212798
20-46724875-C-CGGATGGAT Benign (Nov 14, 2019)1280280
20-46724875-C-CGGATGGATGGATGGAT Benign (Aug 10, 2019)1241818
20-46724875-C-CGGATGGATGGAT Benign (Nov 14, 2019)1237574
20-46724905-GTTTGA-G Likely benign (Aug 06, 2019)1190224
20-46724918-G-GT Likely benign (Jun 14, 2018)676785
20-46724925-A-G Likely benign (Jun 14, 2018)675389

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC2A10protein_codingprotein_codingENST00000359271 526840
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.57e-80.2251256940541257480.000215
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.7553383011.120.00001913399
Missense in Polyphen115112.481.02241316
Synonymous-1.531621391.170.000008861295
Loss of Function0.4351314.80.8788.37e-7160

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006080.000608
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.000.00
European (Non-Finnish)0.0002820.000281
Middle Eastern0.0001630.000163
South Asian0.0001630.000163
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Facilitative glucose transporter.;
Pathway
Nuclear Receptors Meta-Pathway;NRF2 pathway;SLC-mediated transmembrane transport;Transport of small molecules;Fructose and mannose metabolism;Galactose metabolism;Cellular hexose transport (Consensus)

Recessive Scores

pRec
0.180

Intolerance Scores

loftool
0.217
rvis_EVS
0.23
rvis_percentile_EVS
68.52

Haploinsufficiency Scores

pHI
0.116
hipred
N
hipred_score
0.291
ghis
0.481

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.561

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc2a10
Phenotype
renal/urinary system phenotype; immune system phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;

Zebrafish Information Network

Gene name
slc2a10
Affected structure
vasculature
Phenotype tag
abnormal
Phenotype quality
irregular spatial pattern

Gene ontology

Biological process
hexose transmembrane transport;proton transmembrane transport;glucose transmembrane transport
Cellular component
plasma membrane;integral component of plasma membrane;endomembrane system;integral component of membrane;perinuclear region of cytoplasm
Molecular function
carbohydrate:proton symporter activity;D-glucose transmembrane transporter activity